CC
WST icon

Cipher Capital’s West Pharmaceutical WST Stock Holding History

Cipher Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-560
Closed -$214K – 637
2023
Q2 		$214K Buy
+560
New +$200K 0.04% 450
2020
Q4 		– Sell
-1,186
Closed -$326K – 664
2020
Q3 		$326K Sell
1,186
-4,025
-77% -$1.07M 0.04% 391
2020
Q2 		$1.18M Buy
5,211
+3,355
+181% +$659K 0.19% 160
2020
Q1 		$283K Buy
+1,856
New +$286K 0.1% 291

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Cipher Capital's WST Position: Q3 2023 in Review

Cipher Capital sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 560 shares — an estimated $214K sold.

Cipher Capital first reported a position in WST in Q1 2020 and held it in 4 quarters. The position peaked at $1.18M in Q2 2020. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Cipher Capital reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Cipher Capital sold 560 West Pharmaceutical shares in Q3 2023, an estimated $214K.
  • Cipher Capital first reported a position in West Pharmaceutical in Q1 2020 and held it in 4 quarters.
  • Cipher Capital's West Pharmaceutical position peaked at $1.18M in Q2 2020.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Cipher Capital's 13F filing for Q3 2023, filed 14 Nov 2023.